Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.
Also called NCT01070069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 192 participants
- Registry
-
NCT01070069
-
- Other papers using this trial's data
- A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01070069. Randomized; no masking; primary purpose treatment. Start 2010-04-13 (actual); primary completion 2012-03-09 (actual). Results posted on 2022-06-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
- Acronym
- PEVAR
- Condition
- Abdominal Aortic Aneurysm
- Intervention (Device)
- PEVAR (ProGlide closure)
- Intervention (Device)
- SEVAR (IntuiTrak)
- Intervention (Device)
- PEVAR (Prostar XL closure)
- Lead sponsor
- Endologix
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01070069- Content hash
33542da9e9e91dc185b0a87658db700b8c142f3213665b6a4eae07ccf9cfcbfc